On January 17, 2025, at Deutsches Haus Ho Chi Minh City, STADA Pymepharco in collaboration with AHK Vietnam proudly launched the Vietnam Health Report 2024 with the participants of Mr. Dao My, Vice Chairman of Phu Yen Provincial People’s Committee; Dr. Josefine Wallat, German Consul General to Vietnam; Ms. Minh Nguyen, Vice Chairwoman of German Business Association; Mr. Peter Kompalla, Chief Representative of AHK Vietnam, partners and media agencies. The pivotal study evaluates the satisfaction of Vietnamese citizens with the public healthcare system, highlighting the importance of German-Vietnamese collaboration in driving healthcare innovation and quality.
With insights from six key economic regions in Vietnam, the report assesses public satisfaction with healthcare quality, accessibility, and affordability, aiming to shape policies and elevate Vietnam’s healthcare standards.
The event featured an informative panel discussion on the topic of “German Solutions and German Vietnamese Relations in Enhancing Healthcare in Vietnam”.
German Consul General to Vietnam Dr. Josefine Wallat, praised the efforts of STADA Pymepharco, stating: “The Vietnam Health Report is a prime example of effective cooperation between Germany and Vietnam in the healthcare sector. By combining German expertise with local insights, STADA Pymepharco is playing a key role in addressing healthcare challenges and improving patient outcomes”. She appreciated Vietnam’s economic growth and increasing wealth but stresses the need for cost-effective medication to cater not only to affluent populations but also to those with lower incomes”.
Vice Chairman, Phu Yen Provincial People’s Committee, Mr. Dao My, highlighted the province’s focus on completing its socio-economic development plans for 2021-2030, with a vision for 2050, advancing the South Phu Yen economic zone for attracting foreign investment, and creating favorable conditions in infrastructure and administrative procedures. He encouraged collaboration and cultural exchange to explore its abundant natural resources and drive economic growth.
As Vice Chairwoman of the German Business Association (GBA), Ms. Minh Nguyen emphasized the vital contributions of German healthcare companies in shaping Vietnam’s healthcare sector with innovative solutions, advanced technologies, and a commitment to sustainability. She also expressed her belief in the crucial role of German companies across various industries in driving Vietnam’s growth, underscoring the importance of public-private partnerships for long-term development and progress. The launch of the Vietnam Health Report 2024 marks a key moment for STADA Pymepharco as the company embraces its new corporate positioning. “Caring for people’s health as a trusted partner” is STADA’s commitment to providing “German standard” healthcare in Vietnam and worldwide. This commitment underscores the company’s dedication to being a reliable partner in delivering internationally superior quality healthcare solutions that improve lives.
—————————————–
About STADA Pymepharco:
STADA Pymepharco began its journey in 1989 and became a part of the STADA Group in 2021, making us the sole STADA wholly owned affiliate member in Vietnam. STADA Pymepharco is one of the leading pharmaceutical manufacturers in Vietnam and part of a global pharmaceutical leader with nearly 130 years of heritage.
- 2 EU-GMP-certified plants in Tuy Hoa, Phu Yen, each with an annual capacity of nearly 1.5 billion units.
- 1400++ employees nationwide, with 1,000+ employees spread across production sites and office in Tuy Hoa, Phu Yen, 200+ employees at the Ho Chi Minh City Office, & 300+ sales professionals nationwide.
- 27,000 SKUs worldwide with 8,000 Consumer Healthcare (CHC) products.
- 400++ SKUs in our portfolio in Vietnam including 250 Generics (Rx) and 150 CHC, of which around 80 products are assessed as bioequivalents to innovator medicines.
- Trusted by 16,000+ customers and partners, including hospitals, pharmacies, and other pharmaceutical businesses.